Xaira Therapeutics News and Activities
Presence
Xaira Therapeutics develops medicines with artificial intelligence and experimental biology. It offers drug discovery, research platforms, and therapeutic programs for patients and healthcare partners in areas with unmet medical needs.
Xaira Therapeutics products and services overview:
- Drug discovery
- Therapeutic programs
- AI research platforms
- Biology tools
- Precision medicine
Revenue: ~$0 million
Employees: 250
Headquarters: Brisbane, United States (USA)
Xaira Therapeutics is one of the...
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Xaira Therapeutics
- Marc Tessier-Lavign, Chief Executive Officer and Chairman of the B...
- Kaye Foster, Director
- Bryan White, Director
Popular executive movements at Xaira Therapeutics
- Bo Wang who was Senior Vice President and Head of Biomedical Artificial Intelligence, becomes Chief Artificial Intelligence Scientist (posted on July 6 2026).
- Ian McCaffery has joined the company as Senior Vice President, Translational Science and Early Clinical Development (posted on July 6 2026).
- Ci Chu, who was Senior Vice President, Artificial Intelligence Enabled Discovery, is promoted to Chief Discovery Officer (posted on July 6 2026).
Click here to view some more movements at Xaira Therapeutics
Create your alert
to follow the executive moves at Xaira Therapeutics.
Healthcare
Xaira Therapeutics has 3,669 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).
Popular M&A news in Healthcare
- IKS Health has acquired TruBridge (posted on July 10 2026).
- Fore Biotherapeutics has just announced a $67 Million fundraising (posted on July 8 2026).
- Select Medical, listed under ticker , has been delisted. (posted on July 2 2026).
Popular contacts in Healthcare
News
Press releases by Xaira Therapeutics
- Xaira Therapeutics Announces the Appointment of Dr. Ian McCaffery as SVP, Translational Science and Early Clinical Development, and the Promotions of Dr. Ci Chu to Chief Discovery Officer and Dr. Bo Wang to Chief AI Scientist
- Up and down the ladder: The latest comings and goings
- Xaira's First Virtual Cell Model Is Largest To-Date, Toward Complex Biology
- Business Wire
- What David Baker's AI biotech unicorn Xaira has been up to
- Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces
- Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer
- Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell
- X-Atlas/Orion: Xaira Therapeutics Unveils Largest Publicly Available Genome-Wide Perturb-seq Dataset to Power Next-Generation AI for Biology
- Xaira Therapeutics Announces the Appointment of Bo Wang as SVP and Head of Biomedical AI
- View more press releases Close
Social media about Xaira Therapeutics
- Xaira Therapeutics on Wikipedia, Google News & Yahoo Finance
- Xaira Therapeutics on LinkedIn, X (Twitter) & YouTube
